Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “Imatinib”
A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
ClinicalTrials.gov study NCT01126892. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Imatinib for Multiple Sclerosis (MS) Relapses
ClinicalTrials.gov study NCT03674099. IPD Sharing: NO. Countries: 4. Publications: 0.
Evaluating Efficacy and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia(CML-CP) Without Optimal Response (Warning,Failure) to Imatinib or Dasatinib
ClinicalTrials.gov study NCT04681820. IPD Sharing: NO. Countries: 1. Publications: 0.
Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients
ClinicalTrials.gov study NCT01578213. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
ClinicalTrials.gov study NCT01746836. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer
ClinicalTrials.gov study NCT00064285. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
ClinicalTrials.gov study NCT00573404. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib Mesylate in Treating Patients With Recurrent Ewing's Family of Tumors or Desmoplastic Small Round-Cell Tumor
ClinicalTrials.gov study NCT00062205. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate
ClinicalTrials.gov study NCT00298987. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
ClinicalTrials.gov study NCT04933669. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Imatinib 400 mg Once Daily in Combination With Methotrexate in the Treatment of Rheumatoid Arthritis.
ClinicalTrials.gov study NCT00154336. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
ClinicalTrials.gov study NCT01541709. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan
ClinicalTrials.gov study NCT02977312. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)
ClinicalTrials.gov study NCT01483014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
ClinicalTrials.gov study NCT04598009. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
ClinicalTrials.gov study NCT07218926. IPD Sharing: NO. Countries: 5. Publications: 0.
PDR001 Plus Imatinib for Metastatic or Unresectable GIST
ClinicalTrials.gov study NCT03609424. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Patterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)
ClinicalTrials.gov study NCT02034656. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis)
ClinicalTrials.gov study NCT02495519. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma
ClinicalTrials.gov study NCT04042597. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.